Utility of Preoperative Neutrophil/Lymphocyte Ratio as a New Objective Prognostic Tool in Endoscopically Treated Upper Tract Urothelial Carcinoma: A Retrospective Evaluation
- 1 September 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 34 (9) , 993-1000
Abstract
Introduction This exploratory retrospective analysis examined any potential prognostic role of pre-operative NLR for progression free survival (PFS) and time to endoscopically verified upper tract or bladder recurrence free survival (RFS), in upper tract urothelial cancer (UTUC) patients selected for endoscopic treatment with subsequent endo-surveillance. Patients and Methods Eligibility criteria were natural orifice endoscopically retrogradely treated low-risk and imperative UTUC patients treated between 2005-2019, with biopsy confirmed diagnosis and 12 months minimum follow-up. For PFS, optimal NLR cut-off value was derived by log-rank test. Subsequently, both PFS and RFS were assessed for differences using Kaplan–Meier survival curves and log-rank test. Multivariate proportional Cox regression analysis adjusted for clinico-pathological variables was performed to examine end-points for NLR independent prognostic significance. Results There were 100 eligible patients (63 truly low-risk and 37 imperative cases). The optimal PFS log-rank test NLR cut-off value was 2.7. NLR > 2.7 was significantly associated with shorter PFS (p=0.01), and shorter upper tract RFS (p=0.03), but not with bladder RFS (p=0.90). Only positive high-grade cytology (HR 5.92, 95% CI 2.140 – 16.35, p=0.002) and NLR>2.7 (HR 4.28, 95% CI 1.34 – 13.72, p=0.014) independently predicted PFS in multivariate analysis. Recurrence and progression were not significantly linked in the low-risk subset. Conclusions This exploratory analysis showed that baseline NLR evaluation before first endoscopic UTUC treatment may be a valuable predictor and prognosticator of defined disease progression and of upper tract recurrence risk. In conjunction with high-grade urine cytology, NLR may improve risk stratification to optimize future individualized management.Keywords
This publication has 17 references indexed in Scilit:
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular TumoursEuropean Urology, 2016
- Risk-adapted strategy for the kidney-sparing management of upper tract tumoursNature Reviews Urology, 2015
- Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaBritish Journal of Cancer, 2014
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancerCritical Reviews in Oncology/Hematology, 2013
- Preoperative Neutrophil-Lymphocyte Ratio as an Independent Prognostic Marker for Patients With Upper Urinary Tract Urothelial CarcinomaClinical Genitourinary Cancer, 2013
- High-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical ResectionJournal of Endourology, 2012
- Inadequacy of Biopsy for Diagnosis of Upper Tract Urothelial Carcinoma: Implications for Conservative ManagementUrology, 2011
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Cancer-related inflammationNature, 2008
- Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisProceedings of the National Academy of Sciences, 2006